Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel J Sheward

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
The Lancet. Infectious Diseases|September 4, 2022
Evasion of neutralising antibodies by omicron sublineage BA.2.75Daniel J Sheward, Changil Kim, Julian Fischbach, et al.
The Lancet. Infectious Diseases|March 20, 2022
Neutralisation sensitivity of the SARS-CoV-2 omicron (B.1.1.529) variant: a cross-sectional studyDaniel J Sheward, Changil Kim, Roy A Ehling, et al.
The Lancet. Infectious Diseases|October 16, 2022
Omicron sublineage BA.2.75.2 exhibits extensive escape from neutralising antibodiesDaniel J Sheward, Changil Kim, Julian Fischbach, et al.
Nature Microbiology|October 16, 2023
SARS-CoV-2 evolution in the Omicron eraCornelius Roemer, Daniel J Sheward, Ryan Hisner, et al.
Nature Communications|September 5, 2020
An alpaca nanobody neutralizes SARS-CoV-2 by blocking receptor interactionLeo Hanke, Laura Vidakovics Perez, Daniel J Sheward, et al.
Science Advances|March 25, 2022
Multivariate mining of an alpaca immune repertoire identifies potent cross-neutralizing SARS-CoV-2 nanobodiesLeo Hanke, Daniel J Sheward, Alec Pankow, et al.
Cell Systems|September 18, 2025
Synthetic coevolution reveals adaptive mutational trajectories of neutralizing antibodies and SARS-CoV-2Roy A Ehling, Mason Minot, Max D Overath, et al.
Cell Reports. Medicine|November 1, 2021
Beta RBD boost broadens antibody-mediated protection against SARS-CoV-2 variants in animal modelsDaniel J Sheward, Marco Mandolesi, Egon Urgard, et al.
The Journal of Infectious Diseases|November 16, 2014
Differences in HIV type 1 neutralization breadth in 2 geographically distinct cohorts in AfricaGama P Bandawe, Penny L Moore, Lise Werner, et al.
Cell Host & Microbe|October 2, 2018
HIV Superinfection Drives De Novo Antibody Responses and Not Neutralization BreadthDaniel J Sheward, Jinny Marais, Valerie Bekker, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
The Lancet. Infectious Diseases|September 4, 2022
Evasion of neutralising antibodies by omicron sublineage BA.2.75Daniel J Sheward, Changil Kim, Julian Fischbach, et al.
The Lancet. Infectious Diseases|March 20, 2022
Neutralisation sensitivity of the SARS-CoV-2 omicron (B.1.1.529) variant: a cross-sectional studyDaniel J Sheward, Changil Kim, Roy A Ehling, et al.
The Lancet. Infectious Diseases|October 16, 2022
Omicron sublineage BA.2.75.2 exhibits extensive escape from neutralising antibodiesDaniel J Sheward, Changil Kim, Julian Fischbach, et al.
Nature Microbiology|October 16, 2023
SARS-CoV-2 evolution in the Omicron eraCornelius Roemer, Daniel J Sheward, Ryan Hisner, et al.
Nature Communications|September 5, 2020
An alpaca nanobody neutralizes SARS-CoV-2 by blocking receptor interactionLeo Hanke, Laura Vidakovics Perez, Daniel J Sheward, et al.
Science Advances|March 25, 2022
Multivariate mining of an alpaca immune repertoire identifies potent cross-neutralizing SARS-CoV-2 nanobodiesLeo Hanke, Daniel J Sheward, Alec Pankow, et al.
Cell Systems|September 18, 2025
Synthetic coevolution reveals adaptive mutational trajectories of neutralizing antibodies and SARS-CoV-2Roy A Ehling, Mason Minot, Max D Overath, et al.
Cell Reports. Medicine|November 1, 2021
Beta RBD boost broadens antibody-mediated protection against SARS-CoV-2 variants in animal modelsDaniel J Sheward, Marco Mandolesi, Egon Urgard, et al.
The Journal of Infectious Diseases|November 16, 2014
Differences in HIV type 1 neutralization breadth in 2 geographically distinct cohorts in AfricaGama P Bandawe, Penny L Moore, Lise Werner, et al.
Cell Host & Microbe|October 2, 2018
HIV Superinfection Drives De Novo Antibody Responses and Not Neutralization BreadthDaniel J Sheward, Jinny Marais, Valerie Bekker, et al.
Pageof 5